Barclays Raises Viatris Price Target to $25 From $22, Keeps Overweight Rating
Barclays raised its price target on Viatris to $25 from $22 and maintained its Overweight rating.
Barclays raised its price target on Viatris to $25 from $22 and maintained its Overweight rating.